Ramifications of the Myriad gene patent case could reach far beyond medical diagnostics

Ramifications of the Myriad gene patent case could reach far beyond medical diagnostics

The US Supreme Court this week heard oral arguments in Association for Molecular Pathology v Myriad Genetics. The case, which concerns the patentability of human genetic material, could have serious implications for innovators in the biotechnology…

Unlock unlimited access to all IAM content